Literature DB >> 22718340

Determining a definite diagnosis of primary immune thrombocytopenia by medical record review.

Deirdra R Terrell1, Laura A Beebe, Sara K Vesely, Barbara R Neas, Jodi B Segal, James N George.   

Abstract

The objective of this study is to establish a method to identify patients with primary immune thrombocytopenia (ITP) utilizing administrative data from diverse data sources that would be appropriate for epidemiologic studies of ITP, regardless of patients' age and source of health care. Medical records of the Oklahoma University Medical Center, 1995-2004, were reviewed to document the accuracy of the administrative code ICD-9-CM 287.3 for identifying children and adults with ITP, using novel, explicit levels of evidence to identify patients with a definite diagnosis. The proportion of patients diagnosed by hematologists compared to non-hematologists and the proportion of patients diagnosed as outpatients compared to inpatients were determined. For children, age <16 years, 323 outpatient medical records were reviewed; 225 adult outpatient medical records were reviewed. The positive predictive value for the administrative code for identifying patients with a definite diagnosis of ITP by a hematologist was 0.72 in children and 0.69 in adults. In 98% of children and 92% of adults seen as outpatients, the definite diagnosis of ITP was established by a hematologist. One hundred eighteen child and 141 adult inpatient medical records were reviewed. In 95% of children and 83% of adults, the definite diagnosis of ITP by a hematologist was established as an outpatient. This study confirmed the previously reported positive predictive value for the administrative code for identifying patients with ITP. Additionally, it was determined that analysis of hematologists' outpatient administrative codes identified most children and adults with ITP. Am. J. Hematol. 2012. © 2012 Wiley Periodicals, Inc.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22718340      PMCID: PMC3429706          DOI: 10.1002/ajh.23226

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  11 in total

1.  Referral of patients with thrombocytopenia from primary care clinicians to hematologists.

Authors:  Deirdra R Terrell; Laura A Beebe; James N George; Sara K Vesely; James W Mold
Journal:  Blood       Date:  2009-04-23       Impact factor: 22.113

2.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Authors:  Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

Review 3.  The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.

Authors:  Cindy Neunert; Wendy Lim; Mark Crowther; Alan Cohen; Lawrence Solberg; Mark A Crowther
Journal:  Blood       Date:  2011-02-16       Impact factor: 22.113

4.  Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS).

Authors:  P Imbach; T Kühne; D Müller; W Berchtold; S Zimmerman; M Elalfy; G R Buchanan
Journal:  Pediatr Blood Cancer       Date:  2006-03       Impact factor: 3.167

5.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

Review 6.  Idiopathic thrombocytopenic purpura.

Authors:  P H Bolton-Maggs
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

7.  Prevalence of primary immune thrombocytopenia in Oklahoma.

Authors:  Deirdra R Terrell; Laura A Beebe; Barbara R Neas; Sara K Vesely; Jodi B Segal; James N George
Journal:  Am J Hematol       Date:  2012-06-05       Impact factor: 10.047

Review 8.  The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports.

Authors:  Deirdra R Terrell; Laura A Beebe; Sara K Vesely; Barbara R Neas; Jodi B Segal; James N George
Journal:  Am J Hematol       Date:  2010-03       Impact factor: 10.047

Review 9.  International consensus report on the investigation and management of primary immune thrombocytopenia.

Authors:  Drew Provan; Roberto Stasi; Adrian C Newland; Victor S Blanchette; Paula Bolton-Maggs; James B Bussel; Beng H Chong; Douglas B Cines; Terry B Gernsheimer; Bertrand Godeau; John Grainger; Ian Greer; Beverley J Hunt; Paul A Imbach; Gordon Lyons; Robert McMillan; Francesco Rodeghiero; Miguel A Sanz; Michael Tarantino; Shirley Watson; Joan Young; David J Kuter
Journal:  Blood       Date:  2009-10-21       Impact factor: 22.113

10.  Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: a data validation study.

Authors:  Jodi B Segal; Neil R Powe
Journal:  Am J Hematol       Date:  2004-01       Impact factor: 10.047

View more
  3 in total

1.  Immune thrombocytopenia: getting back to basics.

Authors:  Donald M Arnold
Journal:  Am J Hematol       Date:  2012-07-05       Impact factor: 10.047

2.  Prevalence of primary immune thrombocytopenia in Oklahoma.

Authors:  Deirdra R Terrell; Laura A Beebe; Barbara R Neas; Sara K Vesely; Jodi B Segal; James N George
Journal:  Am J Hematol       Date:  2012-06-05       Impact factor: 10.047

3.  Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.

Authors:  Judith C Maro; Jeffrey S Brown; Gerald J Dal Pan; Martin Kulldorff
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-04-03       Impact factor: 2.890

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.